Fetal Cardiac Function Parameters and HbA1c As Screening for Gestational Diabetes Mellitus

NCT05019508 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2025-01-16

No results posted yet for this study

Summary

This is a prospective cohort study to assess the predictive value of fetal cardiac parameters, the change in fetal cardiac parameters (CFP), HbA1c, and/or the change in HbA1c (ΔHbA1c) for gestational diabetes.

Conditions

  • Gestational Diabetes

Sponsors & Collaborators

  • University of Virginia

    lead OTHER

Principal Investigators

  • Christoher Ennen, MD · UVA

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-13
Primary Completion
2022-08-18
Completion
2023-04-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05019508 on ClinicalTrials.gov